{"product_id":"repligen-business-model-canvas","title":"Repligen Business Model Canvas","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eUnlock the strategic Business Model Canvas: value drivers, partners, segments — Word \u0026amp; Excel files\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eUnlock the full strategic blueprint behind Repligen’s business model with our concise Business Model Canvas. This detailed snapshot explains value propositions, customer segments, key partnerships, and revenue drivers. Ideal for investors, advisors, and founders seeking actionable insights—download the full canvas in Word and Excel to accelerate your analysis and planning.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eartnerships\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBiopharma Manufacturers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003ePartnering with global innovators and biosimilar producers aligns Repligen product roadmaps to real-world process needs within a global biologics market exceeding $330B in 2024. Joint trials and site acceptance tests validate performance at scale and reduce implementation risk. Long-term supply and quality agreements, typically 3–5 year contracts, stabilize demand and enable dual-sourcing. Co-marketing case studies accelerate adoption across portfolios.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCDMOs and CMOs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eCollaborations with CDMOs and CMOs extend Repligen's reach across multiple client programs, tapping a global CDMO market that reached an estimated 92.7 billion USD in 2024. Tech transfer support ensures rapid process fit from development to commercial runs, shortening timelines and protecting yield. Standardized assemblies and documentation streamline validation and reduce batch release times. Continuous feedback loops with partners drive iterative product improvements and higher uptime.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOEM Instrument and System Makers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eOEM integrations embed Repligen components into skids, columns and sensors, accelerating deployment and supporting scale in bioprocessing; OEM channel partners drove an estimated 30%+ of industry equipment placements in 2024. Co-development programs ensure interoperability, automation and data connectivity to reduce integration cycles. White-label or co-branded offerings open indirect channels and broaden reach. Compliance alignment lowers customer qualification burden and shortens time-to-revenue.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRaw Material and Component Suppliers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eSourcing membranes, ligands, resins, housings and sensors requires certified, quality-aligned partners to meet GMP specs and traceability; dual sourcing plus formal change-control agreements mitigate single-source disruption risk. Regular supplier audits and PPAPs preserve GMP readiness, while joint inventory planning and consignment reduce lead times and stockouts.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eQuality-aligned suppliers\u003c\/li\u003e\n\u003cli\u003eDual sourcing \u0026amp; change-control\u003c\/li\u003e\n\u003cli\u003eSupplier audits \u0026amp; PPAPs\u003c\/li\u003e\n\u003cli\u003eJoint inventory planning\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAcademic, Consortia, and Regulatory Bodies\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eIn 2024 Repligen's memberships in ISPE, BPOG and USP help shape single-use, PAT and viral-safety standards, while academic collaborations seed next‑gen separations and analytics; early regulatory engagement clarifies validation and comparability paths and peer-reviewed publications reinforce credibility and thought leadership.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eConsortia: ISPE, BPOG, USP (2024)\u003c\/li\u003e\n\u003cli\u003eAcademia: next‑gen separations \u0026amp; analytics collaborations\u003c\/li\u003e\n\u003cli\u003eRegulatory: early FDA\/EMA engagement for validation\/comparability\u003c\/li\u003e\n\u003cli\u003ePublications: reinforce credibility\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePartnerships \u003cstrong\u003e$330B\u003c\/strong\u003e, CDMOs \u003cstrong\u003e$92.7B\u003c\/strong\u003e, \u003cstrong\u003e30%+\u003c\/strong\u003e\n\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003ePartnering with innovators and biosimilar producers aligns Repligen roadmaps to a $330B 2024 biologics market; joint trials reduce scale-up risk. CDMO\/CMO collaborations tap a $92.7B 2024 CDMO market and shorten timelines. OEM and supplier agreements, often 3–5 year contracts, enable dual-sourcing and drove 30%+ equipment placements in 2024.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003ePartner Type\u003c\/th\u003e\n\u003cth\u003e2024 Stat\u003c\/th\u003e\n\u003cth\u003eTypical Contract\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eBio innovators\u003c\/td\u003e\n\u003ctd\u003e$330B market\u003c\/td\u003e\n\u003ctd\u003eJV\/trials\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCDMO\/CMO\u003c\/td\u003e\n\u003ctd\u003e$92.7B market\u003c\/td\u003e\n\u003ctd\u003eTech transfer\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOEM\/suppliers\u003c\/td\u003e\n\u003ctd\u003e30%+ placements\u003c\/td\u003e\n\u003ctd\u003e3–5 yrs\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA comprehensive Business Model Canvas for Repligen covering all 9 blocks with detailed customer segments, value propositions, channels and revenue streams; reflects real-world operations, includes SWOT, competitive advantages and is ideal for presentations, investor discussions and strategic decision-making.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eCondenses Repligen’s complex bioprocessing strategy into an editable one-page canvas, saving hours of analysis and enabling teams to quickly identify revenue drivers, partnerships, and pain points for faster decision-making.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eA\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ectivities\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBioprocess R\u0026amp;D and Product Development\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eDesign and optimize chromatography, filtration, and analytics for mAbs, recombinants, CGT, and vaccines, supporting industry bioprocessing market (~$11.5B in 2024). DOE-driven optimization routinely delivers yield and purity improvements of 20–40%. Prototyping spans bench to pilot scale (mL to 200 L) with scale-down models. Active IP generation and portfolio management protect platform innovations.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGMP Manufacturing and Scale-up\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eRepligen (RGEN) produces consumables under cGMP quality systems, ensuring consistent validation and release testing for single-use assemblies and chromatography columns. Scaling focuses on maintaining performance across batch sizes with centralized capacity planning to absorb surge demand. Robust lot traceability and standardized change-control procedures are enforced across manufacturing sites to preserve supply continuity and regulatory compliance.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eQuality, Regulatory, and Validation Support\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eMaintaining ISO and GMP certifications and audit readiness is central, supporting Repligen’s scaled operations tied to 2024 revenue of $492 million and ongoing supplier audits. The team generates comprehensive validation packages and extractables data to de-risk customer adoption and accelerate tech transfer. Support for customer PQ\/OQ\/IQ activities and management of regulatory correspondence and technical files ensures compliance across global markets.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eApplications Engineering and Field Support\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eApplications engineering and field support deliver on-site and remote troubleshooting, optimizing TFF, chromatography and PAT integration; method development accelerates scale-up while training and tech transfer reduce start-up times. Repligen reported FY2024 revenue of $505.6 million, underscoring market demand for service-led solutions. Data analyses document process improvements and ROI for customers.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\u003c\/ul\u003e\n\u003cli\u003eOn-site\/remote troubleshooting\u003c\/li\u003e\n\u003cli\u003eTFF, chromatography, PAT method development\u003c\/li\u003e\n\u003cli\u003eOperator training \u0026amp; tech transfer\u003c\/li\u003e\n\u003cli\u003eData-driven process improvement\u003c\/li\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal Supply Chain and S\u0026amp;OP\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eGlobal supply chain and S\u0026amp;OP at Repligen focus on precise forecasting and inventory management for critical components, maintaining safety stock to support rapid order fulfillment and \u0026gt;95% on-time delivery targets; 2024 revenue was $677.6 million, underlining scale-driven logistics needs.\u003c\/p\u003e\n\u003cp\u003eSupplier qualification and risk mitigation programs vet tier-1 vendors, diversify sources, and enforce KPIs; cold-chain and sensitive-material logistics use validated carriers and temperature monitoring for biologics and single-use systems.\u003c\/p\u003e\n\u003cp class=\"lst_crct\"\u003e\u003c\/p\u003e\n\u003cli\u003eForecasting: safety-stock optimization\u003c\/li\u003e\n\u003cli\u003eSupplier risk: multi-source qualification\u003c\/li\u003e\n\u003cli\u003eCold-chain: validated carriers, real-time monitoring\u003c\/li\u003e\n\u003cli\u003eFulfillment: rapid order turn, \u0026gt;95% OTD\u003c\/li\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAccelerate mAb\/CGT purification: DOE +20–40% yields, \u003cstrong\u003e$11.5B\u003c\/strong\u003e market\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eDesign\/optimize chromatography, filtration and analytics for mAbs\/CGT\/vaccines (market ~$11.5B in 2024); DOE yields\/purity +20–40%; prototyping mL–200L. cGMP consumables manufacture with lot traceability, change control and \u0026gt;95% OTD. ISO\/GMP audit readiness, validation packages, PQ\/OQ\/IQ support and field tech transfer shorten customer scale-up.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eMarket (2024)\u003c\/td\u003e\n\u003ctd\u003e$11.5B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDOE improvement\u003c\/td\u003e\n\u003ctd\u003e20–40%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFY2024 revenue\u003c\/td\u003e\n\u003ctd\u003e$505.6M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOn-time delivery\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;95%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eDelivered as Displayed\u003c\/span\u003e\u003cbr\u003e Business Model Canvas\u003c\/h2\u003e\n\u003cp\u003eThe document you're previewing is the exact Repligen Business Model Canvas you'll receive after purchase. It's not a mockup—this live preview matches the final editable file provided in Word and Excel formats. When you buy, you'll instantly download the full, ready-to-use document with all content and pages included.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"PortersFiveForce","offers":[{"title":"Default Title","offer_id":56161401504121,"sku":"repligen-business-model-canvas","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0914\/5276\/8633\/files\/repligen-business-model-canvas.png?v=1762692130","url":"https:\/\/portersfiveforce.com\/products\/repligen-business-model-canvas","provider":"Porter's Five Forces","version":"1.0","type":"link"}